Literature DB >> 25511849

Systemic sclerosis induces pronounced peripheral vascular dysfunction characterized by blunted peripheral vasoreactivity and endothelial dysfunction.

Tracy Frech1, Ashley E Walker, Zachary Barrett-O'Keefe, Paul N Hopkins, Russell S Richardson, D Walter Wray, Anthony J Donato.   

Abstract

Systemic sclerosis (SSc) vasculopathy can result in a digital ulcer (DU) and/or pulmonary arterial hypertension (PAH). We hypothesized that bedside brachial artery flow-mediated dilation (FMD) testing with duplex ultrasound could be used in SSc patients to identify features of patients at risk for DU or PAH. Thirty-eight SSc patients were compared to 52 age-matched healthy controls from the VAMC Utah Vascular Research Laboratory. Peripheral hemodynamics, arterial structure, and endothelial function were assessed by duplex ultrasound. A blood pressure cuff was applied to the forearm and 5-min ischemia was induced. Post-occlusion, brachial artery vascular reactivity (peak hyperemia/area under the curve [AUC]), shear rate, and endothelial function (FMD) were measured. SSc patients had smaller brachial artery diameters (p < 0.001) and less reactive hyperemia (p < 0.001), peak shear rate (p = 0.03), and brachial artery FMD (p < 0.001) compared with healthy controls. Brachial artery FMD was lower (p < 0.05) in SSc patients with DU. Tertile analysis suggested the 2 lower FMD tertiles (<5.40 %) had a 40-50 % chance of presenting with DU while the SSc patients with highest FMD tertile (>5.40 %) had less than 15 % chance of DU. All brachial artery FMD measurements were similar between SSc patients with and without PAH (all p > 0.05). Compared to healthy controls, SSc patients had significantly smaller brachial artery diameter and blunted peripheral vascular reactivity and endothelial function. SSc patients with DU have even greater impairments in endothelial function compared to those without DU. FMD testing has clinical utility to identify SSc patients at risk for DU.

Entities:  

Mesh:

Year:  2014        PMID: 25511849      PMCID: PMC4757465          DOI: 10.1007/s10067-014-2834-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  51 in total

Review 1.  Criteria for the classification of early systemic sclerosis.

Authors:  E C LeRoy; T A Medsger
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

2.  Developing the guidelines for preventive care - two decades of experience.

Authors:  Mark F Harris; Linda Bailey; Teri Snowdon; John Litt; Jane W Smith; Beres Joyner; John Furler
Journal:  Aust Fam Physician       Date:  2010 Jan-Feb

3.  Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia.

Authors:  M J Mullen; R K Kharbanda; J Cross; A E Donald; M Taylor; P Vallance; J E Deanfield; R J MacAllister
Journal:  Circ Res       Date:  2001-02-02       Impact factor: 17.367

4.  Endogenous prostaglandins as local regulators of blood flow in man: effect of indomethacin on reactive and functional hyperaemia.

Authors:  A Kilbom; A Wennmalm
Journal:  J Physiol       Date:  1976-05       Impact factor: 5.182

5.  From Belfast to Mayo and beyond: the use and future of plethysmography to study blood flow in human limbs.

Authors:  M J Joyner; N M Dietz; J T Shepherd
Journal:  J Appl Physiol (1985)       Date:  2001-12

6.  Contribution of nicotine to acute endothelial dysfunction in long-term smokers.

Authors:  Thomas Neunteufl; Sandra Heher; Karam Kostner; Goran Mitulovic; Stephan Lehr; Gholamali Khoschsorur; Rainer W Schmid; Gerald Maurer; Thomas Stefenelli
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperaemia.

Authors:  I Carlsson; A Sollevi; A Wennmalm
Journal:  J Physiol       Date:  1987-08       Impact factor: 5.182

9.  Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing.

Authors:  Iratxe Eskurza; Kevin D Monahan; Jed A Robinson; Douglas R Seals
Journal:  J Physiol       Date:  2004-01-30       Impact factor: 5.182

10.  Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production.

Authors:  Grethe Neumann Andersen; Lucia Mincheva-Nilsson; Elsadig Kazzam; Gunnar Nyberg; Natalia Klintland; Ann-Sofi Petersson; Solbritt Rantapää-Dahlqvist; Anders Waldenström; Kenneth Caidahl
Journal:  Arthritis Rheum       Date:  2002-05
View more
  14 in total

1.  Attenuated nitric oxide bioavailability in systemic sclerosis: Evidence from the novel assessment of passive leg movement.

Authors:  Heather L Clifton; Daniel R Machin; H Jonathan Groot; Tracy M Frech; Anthony J Donato; Russell S Richardson; D Walter Wray
Journal:  Exp Physiol       Date:  2018-08-18       Impact factor: 2.969

2.  Non-invasive digital thermal monitoring and flow-mediated dilation in systemic sclerosis.

Authors:  Tracy M Frech; Maureen A Murtaugh
Journal:  Clin Exp Rheumatol       Date:  2019-09-17       Impact factor: 4.473

3.  Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypertension: a systematic review and meta-analysis.

Authors:  Marieta P Theodorakopoulou; Ioanna Minopoulou; Pantelis Sarafidis; Vassilios Kamperidis; Christodoulos Papadopoulos; Theodoros Dimitroulas; Afroditi K Boutou
Journal:  Rheumatol Int       Date:  2021-04-08       Impact factor: 2.631

4.  Exercise-induced brachial artery blood flow and vascular function is impaired in systemic sclerosis.

Authors:  Daniel R Machin; Heather L Clifton; Ryan S Garten; Jayson R Gifford; Russell S Richardson; D Walter Wray; Tracy M Frech; Anthony J Donato
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

5.  Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis.

Authors:  Daniel R Machin; Heather L Clifton; Russell S Richardson; D Walter Wray; Anthony J Donato; Tracy M Frech
Journal:  Clin Exp Rheumatol       Date:  2017-09-14       Impact factor: 4.473

6.  Comparison of clinical and serological parameters in female and male patients with systemic sclerosis.

Authors:  Ewa Wielosz; Maria Majdan; Magdalena Dryglewska; Dorota Suszek
Journal:  Reumatologia       Date:  2016-02-11

7.  Endothelial dysfunction in patients with granulomatosis with polyangiitis: a case-control study.

Authors:  Renata Pacholczak; Stanisława Bazan-Socha; Teresa Iwaniec; Lech Zaręba; Stan Kielczewski; Jerzy A Walocha; Jacek Musiał; Jerzy Dropiński
Journal:  Rheumatol Int       Date:  2018-05-30       Impact factor: 2.631

8.  Review of local wound management for scleroderma-associated digital ulcers.

Authors:  Nicholas Lebedoff; Tracy M Frech; Victoria K Shanmugam; Aryeh Fischer; Daniel Erhardt; Jason Kolfenbach; Kevin Kohler; Kurt Bernhisel; Giavonni M Lewis
Journal:  J Scleroderma Relat Disord       Date:  2017-11-17

9.  Raynaud Phenomenon in Systemic Sclerosis: Does Digital Thermal Monitoring Correlate to Specific Nailfold Videocapillaroscopy Abnormalities?

Authors:  Julie K Thomas; Mislav Radic; Jordan R Tucker; Rebecca Overbury; Tracy M Frech
Journal:  J Rheumatol       Date:  2020-06-15       Impact factor: 4.666

10.  Peripheral microcirculatory abnormalities are associated with cardiovascular risk in systemic sclerosis: a nailfold video capillaroscopy study.

Authors:  Eleni Pagkopoulou; Stergios Soulaidopoulos; Eva Triantafyllidou; Alexandra Arvanitaki; Niki Katsiki; Chalarampos Loutradis; Asterios Karagiannis; Michael Doumas; Alexandros Garyfallos; George D Kitas; Theodoros Dimitroulas
Journal:  Clin Rheumatol       Date:  2021-07-27       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.